title: Treatment with infliximab may contribute to the development of peripheral neuropathy among the patients with rheumatoid arthritis.
authors.forename: Przemyslaw J
authors.initials: PJ
authors.lastname: Kotyla
authors.forename: Bogna
authors.initials: B
authors.lastname: Sliwinska-Kotyla
authors.forename: Eugene J
authors.initials: EJ
authors.lastname: Kucharz
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D004576:Electromyography; D005260:Female; D006801:Humans; D000069285:Infliximab; D008297:Male; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced*; D011446:Prospective Studies; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab